发明名称 Method of treatment and/or prevention of brain, spinal or nerve injury
摘要 The invention relates to a method of treatment and/or prevention of brain, spinal or nerve injury comprising administration to a person in need of such treatment, of a therapeutically effective amount of an NK-1 receptor antagonist compound of the formula wherein the meanings of R, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, and R<SUP>4 </SUP>are explained in the specification and the pharmaceutically acceptable acid addition salts and the prodrugs thereof either alone or in combination with a magnesium salt. Exemplified is the use of N-(3,5-bis-trifluoromethyl-benzyl)-N-methyl-6-(4-methyl-piperazin-1-yl)-4-o-tolyl-nicotinamide. The invention also relates to pharmaceutical composition comprising one or more such NK-1 receptor antagonists, optionally in combination with a magnesium salt, and a pharmaceutically acceptable excipient for the treatment and/or prevention of brain, spinal or nerve injury.
申请公布号 US2006247240(A1) 申请公布日期 2006.11.02
申请号 US20060481216 申请日期 2006.07.05
申请人 HOFFMANN TORSTEN;NIMMO ALAN;SLEIGHT ANDREW;VANKAN PIERRE;VINK ROBERT 发明人 HOFFMANN TORSTEN;NIMMO ALAN;SLEIGHT ANDREW;VANKAN PIERRE;VINK ROBERT
分类号 A61K31/5377;C07D213/74;A61K31/435;A61K31/4418;A61K31/4436;A61K31/4439;A61K31/444;A61K31/4545;A61K31/455;A61K31/496;A61K31/506;A61K31/5355;A61K31/541;A61K39/395;A61P1/04;A61P1/08;A61P11/06;A61P25/00;A61P25/04;A61P25/06;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/36;A61P27/02;A61P27/16;A61P29/00;A61P37/08;A61P43/00;C07D213/75;C07D213/82;C07D401/04;C07D401/12;C07D409/04;C07D413/04;C07D413/12 主分类号 A61K31/5377
代理机构 代理人
主权项
地址